June 22, 2018
Santhera’s Raxone Early Acces to Medicines Scheme renewed in UK
Santhera Pharmaceuticals’s Raxone has been renewed in UK, as the nation’s Medicines and Healthcare products Regulatory Agency (MHRA) has renewed…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Approval
June 22, 2018
Destiny Pharma names new non-executive director
Destiny Pharm has consolidate its board with appointing Nick Rodgers as an independent Non-Executive Director with immediate effect.
June 21, 2018
OptiBiotix secures 10 year presence of its LPLDL in Italy
OptiBiotix Health, a producer of obesity tackling products, and high cholesterol, diabetes and skin care, has ensured its cholesterol and…
June 20, 2018
Idorsia enrolls first patient into Precision phase 3 study of aprocitentan for resistant hypertension management in adults
Idorsia has enrolled the first patient into its Phase 3 study called Precision to investigate the efficacy and safety of…
June 20, 2018
Novo Nordisk shows oral semaglutide more effective in lowering glucose and body weight than Victoza
Novo Nordisk on Wednesday said that it has completed headline results of the phase 3a trials PIONEER 4 comparing oral…
June 19, 2018
Sanofi wraps up €3,9 billion acquisition of Ablynx
Sanofi and Ablynx have completed the acquisition, as Sanofi has acquired all outstanding shares, warrants and convertible bonds of Ablynx.
June 18, 2018
Alcon AcrySof IQ PanOptix trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery
Novartis’s eye care division Alcon unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ…
June 18, 2018
Idorsia starting study to test clazosentan in certain cereblar ischemia patients
Idorsia today is initiating a Phase 3 study React to test clazosentan for the prevention of clinical deterioration due to…
June 14, 2018
Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site
Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare…
June 13, 2018
TiGenix’s CEO leaves as operations integrate into Takeda
TiGenix NV’s Chief Executive Officer, Eduardo Bravo will depart the board of directors and his role as CEO of TiGenix…